SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Unquoted Biotechs
An SI Board Since July 2001
Posts SubjectMarks Bans
253 23 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
78Biovitrum signs agreement to become sole supplier of Wyeth's Hemophilia drugnigel bates-1/26/2004
77Synthon Reaches Pact With GlaxoSmithKline Thu Jan 15 12:59:41 2004 Synthon ReJohn McCarthy-1/15/2004
76Sunesis Announces Extension of Small Molecule Collaboration with Johnson & Jnigel bates-1/15/2004
75GB Therapeutics' GT 1061, Targeted To Alzheimer's Disease, Proceeds To HJohn McCarthy-1/8/2004
74Perlegen Sciences Teams with Pfizer to Focus on Drugs for Major Depression ThurJohn McCarthy-1/8/2004
73Infinity Announces Small Molecule Collaboration With Amgen CAMBRIDGE, Mass., Janigel bates-1/8/2004
72Microbia Announces Successful Development of Advanced Biomanufacturing Process fnigel bates-10/27/2003
71Dow and Avidex Agree to Develop Biotargeted Radiopharmaceuticals Based on mTCR Tnigel bates-9/2/2003
70Entelos and MIT to Study Causes of Immune and Inflammatory Diseases Thursday Julnigel bates-7/17/2003
69We'll see. The practical applications escape me, unless they believe that tscaram(o)uche-6/23/2003
68Avidex Generates High Affinity Monoclonal T Cell Receptors OXFORD, England, Junnigel bates-6/23/2003
67[Sunesis -- Novel anti-cancer concept] >>Published online before print Jutuck-6/13/2003
66A little old... Adprotech's APT070 enters Phase IIa trials in kidney transpnigel bates-4/25/2003
65HEIDELBERG, Germany, April 3 /PRNewswire/ -- Graffinity Pharmaceuticals AG, a lenigel bates-4/3/2003
64SOUTH SAN FRANCISCO, Calif., March 12 /PRNewswire/ -- Sunesis Pharmaceuticals, Inigel bates-3/12/2003
63Microbia and Ranbaxy could use this tool? Must be PURE GENIUS behind these compscaram(o)uche-2/25/2003
62Microbia, Ranbaxy Announce Collaboration to Advance Pharmaceutical Biomanufacturnigel bates-2/25/2003
61TransTech Pharma, Inc. Announces Completion of Preferred Stock Agreements Totalidalroi-2/6/2003
60Message 18538035scaram(o)uche-2/5/2003
59SOUTH SAN FRANCISCO, Dec. 18 /PRNewswire/ -- Sunesis Pharmaceuticals, Inc. announigel bates-12/18/2002
58CAMBRIDGE, U.K., Dec. 12, 2002 (PRIMEZONE) -- Astex Technology, the structure-banigel bates-12/12/2002
57HAMBURG -(Dow Jones)- Evotec OAI AG , a partner for integrated high- value-addednigel bates-12/6/2002
56Maybe time to set up a thread for Sequitur - a full text search invariably givesnigel bates-11/21/2002
55Charles River Laboratories and Proteome Systems Launch Joint Venture in ProteomiRobert Laird-10/28/2002
54Proteome Systems and Itochu launch proteomics company in Japan Sydney, AustraliaRobert Laird-10/28/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News